Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics Inc | RCV000517712 | SCV000615174 | benign | not specified | 2020-09-11 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000762581 | SCV000892914 | uncertain significance | not provided | 2018-05-01 | criteria provided, single submitter | clinical testing | |
Genomic Research Center, |
RCV000791112 | SCV000930386 | uncertain significance | Amyotrophic lateral sclerosis type 4 | 2019-04-27 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001503652 | SCV001708508 | likely benign | Amyotrophic lateral sclerosis type 4; Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2 | 2023-12-28 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002319518 | SCV002606779 | benign | Inborn genetic diseases | 2021-09-02 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV003942701 | SCV004759774 | likely benign | SETX-related condition | 2020-06-08 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |